Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients

NCT00121810 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: mycophenolate mofetil [CellCept]
DRUG: Corticosteroids
DRUG: Calcineurin inhibitors
DRUG: Sirolimus

Sponsor

Hoffmann-La Roche